Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Total 13F shares
-
24,408,139
-
Share change
-
+5,836,181
-
Total reported value
-
$75,666,380
-
Price per share
-
$3.10
-
Number of holders
-
83
-
Value change
-
+$18,659,806
-
Number of buys
-
59
-
Number of sells
-
16
Institutional Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q2 2020
As of 30 Jun 2020,
HARVARD BIOSCIENCE INC - Common Stock (HBIO) was held by
83 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,408,139 shares.
The largest 10 holders included
BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, ROYCE & ASSOCIATES LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, DALTON GREINER HARTMAN MAHER & CO, KENNEDY CAPITAL MANAGEMENT, INC., ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., and HEARTLAND ADVISORS INC.
This page lists
83
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.